From: Mammographic parameters as predictors of molecular subtype of breast cancer: a prospective analysis
Calcifications | Her-neu enriched type (n = 9) | Luminal type A (n = 17) | Luminal type B (Her -ve) (n = 6) | Luminal type B (Her + ve) (n = 9) | Triple negative type (n = 10) | Total | P value |
Absent | 1 (4.17%) | 11 (45.83%) | 4 (16.66%) | 0 (0%) | 8 (33.33%) | 24 (100%) | < .0001* |
Present | 8 (29.63%) | 6 (22.22%) | 2 (07.40%) | 9 (33.33%) | 2 (7.41%) | 27 (100%) | |
Total | 9 (17.65%) | 17 (33.33%) | 6 (11.76%) | 9 (17.65%) | 10 (19.61%) | 51 (100%) | |
Suspicious morphology calcifications | Her-neu enriched type (n = 8) | Luminal type A (n = 6) | Luminal type B (Her -ve) (n = 2) | Luminal type B (Her + ve) (n = 9) | Triple negative type (n = 2) | Total | P value |
Amorphous | 5 (35.71%) | 3 (21.43%) | 0 | 5 (35.71%) | 1 (7.14%) | 14 (100%) | 0.369* |
Coarse heterogenous | 1 (50%) | 0 (0%) | 0 | 1 (50%) | 0 (0%) | 2 (100%) | |
Fine linear | 0 (0%) | 0 (0%) | 0 | 1 (50%) | 1 (50%) | 2 (100%) | |
Fine pleomorphic | 2 (22.22%) | 3 (33.33%) | 2 (22.22%) | 2 (22.22%) | 0 (0%) | 9 (100%) | |
Total | 8 (29.63%) | 6 (22.22%) | 2 (7.41%) | 9 (33.33%) | 2 (7.41%) | 27 (100%) | |
Distribution of calcification | Her-neu enriched type(n = 8) | Luminal type A(n = 6) | Luminal type B (Her -ve) (n = 2) | Luminal type B(n = 9) | Triple negative type(n = 2) | Total | P value |
Grouped | 6 (27.27%) | 5 (22.72%) | 2 (09.09%) | 8 (36.36%) | 1 (4.55%) | 22 (100%) | 0.378* |
Regional | 2 (50%) | 1 (25%) | 0 | 0 (0%) | 1 (25%) | 4 (100%) | |
Segmental | 0 (0%) | 0 (0%) | 0 | 1 (100%) | 0 (0%) | 1 (100%) | |
Total | 8 (29.63%) | 6 (22.22%) | 2 (07.40%) | 9 (33.33%) | 2 (7.41%) | 27 (100%) |